Puma Biotechnology, Inc. (PBYI) has established a robust uptrend on the daily chart. The stock has surged approximately 12.60% in the last month and over 150% in the past year, reflecting sustained bullish momentum. Price has consistently formed higher highs and higher lows, breaking through key resistance levels such as the prior 52-week low of 2.58. This structure confirms the prevailing uptrend, with the stock now testing the upper end of its 52-week range at 7.68.
Traders are eyeing the 52-week high at 7.68 as primary resistance, where selling pressure may emerge. Pivot points provide near-term levels: classic pivot at 7.30, with immediate support at 7.26 (S1) and resistance at 7.35 (R1). Deeper support aligns with recent lows around 6.61 and the 20-day moving average near 6.98. These zones, derived from prior price action and Fibonacci pivots, act as supply and demand areas watched by market participants.
All simple and exponential moving averages signal buy. The 5-day SMA stands at 7.28, 20-day at 6.98, 50-day at 6.68, 100-day at 6.45, and 200-day at 6.32. The price trading well above the 200-day MA underscores the long-term bullish bias, with shorter-term averages providing dynamic support during pullbacks. This alignment, including a golden cross where the 50-day crossed above the 200-day, reinforces trend continuation potential.
Momentum remains bullish, led by a positive MACD (12,26) at 0.184 signaling buy. RSI(14) at 78.512 indicates overbought territory, suggesting possible short-term consolidation, while STOCH(9,6) at 77.995 and CCI(14) at 150.77 both flash buy. ADX(14) at 36.88 confirms strong trend strength. These readings highlight robust buying interest, though overbought conditions warrant caution for near-term reversals.
Volume has accompanied the recent advance, averaging around 400K shares daily, with spikes supporting breakouts. Current sessions show volume near 300K, aligning with price gains and indicating conviction among buyers. Elevated activity relative to the 65-day average underscores participation in the uptrend.
Tickeron’s AI Daily Buy/Sell Signals leverage artificial intelligence to scrutinize vast datasets, including technical indicators, price patterns, and historical trends, generating actionable buy or sell signals for stocks like PBYI. These signals draw from pattern recognition, momentum shifts, and trend analysis to pinpoint potential entry and exit opportunities, helping traders validate setups and refine strategies. By processing real-time market behavior against proven historical precedents, the AI aids in confirming bullish continuations or reversal risks. Explore these insights to enhance your trading decisions.
Traders will monitor for a decisive move above 7.68 to confirm further upside, or a pullback to test support near 7.26 and 6.98. Watch RSI for divergence signaling exhaustion, MACD histogram for momentum shifts, and volume for confirmation on any breakout. The 50-day MA at 6.68 serves as pivotal support in the event of consolidation. Overall, the structure favors bulls barring a breakdown below key pivots.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.
A.I.dvisor indicates that over the last year, PBYI has been loosely correlated with RNA. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if PBYI jumps, then RNA could also see price increases.
| Ticker / NAME | Correlation To PBYI | 1D Price Change % | ||
|---|---|---|---|---|
| PBYI | 100% | +1.20% | ||
| RNA - PBYI | 36% Loosely correlated | +0.88% | ||
| DSGN - PBYI | 33% Poorly correlated | -1.08% | ||
| RNAC - PBYI | 31% Poorly correlated | -3.45% | ||
| COGT - PBYI | 30% Poorly correlated | -0.70% | ||
| INVA - PBYI | 30% Poorly correlated | +1.76% | ||
More | ||||